X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (18) 18
index medicus (18) 18
humans (17) 17
male (15) 15
female (14) 14
infliximab (14) 14
middle aged (14) 14
inflammatory bowel disease (13) 13
crohn's disease (11) 11
ulcerative colitis (11) 11
adult (8) 8
rheumatoid arthritis (8) 8
adalimumab (7) 7
aged (6) 6
arthritis, rheumatoid - genetics (6) 6
calprotectin (6) 6
crohns-disease (6) 6
validation (6) 6
immunology (5) 5
pharmacology & pharmacy (5) 5
polymorphism, single nucleotide (5) 5
prospective studies (5) 5
rheumatology (5) 5
risk (5) 5
treatment outcome (5) 5
arthritis, rheumatoid - drug therapy (4) 4
artritis reumatoide (4) 4
association (4) 4
c-reactive protein (4) 4
cancer (4) 4
genotype (4) 4
inflammatory-bowel-disease (4) 4
markers (4) 4
multidisciplinary sciences (4) 4
oncology (4) 4
polymorphisms (4) 4
recurrence (4) 4
research article (4) 4
single nucleotide polymorphisms (4) 4
single-nucleotide polymorphism (4) 4
surgery (4) 4
therapy (4) 4
ulcerative-colitis (4) 4
young adult (4) 4
anaemia (3) 3
anemia (3) 3
antirheumatic agents - therapeutic use (3) 3
anxiety (3) 3
arthritis (3) 3
biomarkers (3) 3
case-control studies (3) 3
ciclosporin (3) 3
clinical medicine (3) 3
clinical practice (3) 3
criteria (3) 3
crohn disease - diagnosis (3) 3
crohn’s disease (3) 3
depression (3) 3
diagnosis (3) 3
enfermedad inflamatoria intestinal (3) 3
feces - chemistry (3) 3
genes (3) 3
genetic aspects (3) 3
genome-wide association (3) 3
ibd (3) 3
intravenous iron (3) 3
medical research (3) 3
medicine, experimental (3) 3
methotrexate (3) 3
patients (3) 3
prognosis (3) 3
quality-of-life (3) 3
risk factors (3) 3
smoking (3) 3
survey (3) 3
time factors (3) 3
tumor necrosis factor alpha (3) 3
tumor necrosis factor-alpha - antagonists & inhibitors (3) 3
tumor necrosis factor-tnf (3) 3
adalimumab - therapeutic use (2) 2
aged, 80 and over (2) 2
analysis (2) 2
anti-inflammatory agents - therapeutic use (2) 2
anti-tnf (2) 2
carcinoma, hepatocellular - surgery (2) 2
clinical practice guidelines (2) 2
clinical-course (2) 2
cohort (2) 2
colitis ulcerosa (2) 2
colitis, ulcerative - drug therapy (2) 2
crohn disease - drug therapy (2) 2
cross-sectional studies (2) 2
development and progression (2) 2
diseases of the digestive system. gastroenterology (2) 2
dosage and administration (2) 2
double-blind (2) 2
drug therapy (2) 2
efficacy (2) 2
endoscopic remission (2) 2
endoscopy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLOS ONE, ISSN 1932-6203, 02/2019, Volume 14, Issue 2, p. e0213073
Journal Article
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 10/2019, Volume 54, Issue S1, pp. 19 - 19
Journal Article
United European Gastroenterology Journal, ISSN 2050-6406, 7/2018, Volume 6, Issue 6, pp. 952 - 954
Journal Article
Nature Communications, ISSN 2041-1723, 2018, Volume 9, Issue 1, pp. 3927 - 12
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 04/2019, Volume 53, Issue 4, pp. 315 - 316
Journal Article
JOURNAL OF CLINICAL GASTROENTEROLOGY, ISSN 0192-0790, 03/2018, Volume 52, Issue 3, pp. 229 - 234
Background and Goal: Predicting relapse in inflammatory bowel disease (IBD) patients could allow early changes in therapy. We aimed at evaluating the accuracy... 
PROTEIN | CROHNS-DISEASE | INDUCTION THERAPY | calprotectin | infliximab | ULCERATIVE-COLITIS | MARKERS | RISK | GASTROENTEROLOGY & HEPATOLOGY | inflammatory bowel disease | adalimumab | INFLIXIMAB THERAPY | Inflammatory bowel diseases | Dosage and administration | Diagnosis | Drug therapy | Tumor necrosis factor inhibitors
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 08/2019, Volume 50, Issue 3, pp. 278 - 288
Summary Background There are limited data of ustekinumab administered according to the doses recommended in the UNITI studies. Aim To assess the real‐world,... 
Intolerance | Demographics | Endoscopes | Remission | Crohn's disease | Tumor necrosis factor-α | Disease control
Journal Article
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 3/2019, Volume 64, Issue 3, pp. 846 - 854
Journal Article
Pharmacogenomics Journal, ISSN 1470-269X, 07/2018, Volume 18, Issue 4, pp. 539 - 545
Journal Article
Journal Article
Journal of Crohn's and Colitis, ISSN 1873-9946, 01/2019, Volume 13, Issue Supplement_1, pp. S358 - S359
Abstract Background There is no evidence about the time that it is reasonable to wait until starting the second anti TNF in case of loss of response. The aim... 
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2013, Volume 71, Issue Suppl 3, pp. 658 - 658
Background There is a need to identify subgroups of patients with RA having a more uniform phenotype. HLA-B27 is a good candidate to affect the RA phenotype... 
Journal Article
Journal of Crohn's and Colitis, ISSN 1873-9946, 01/2019, Volume 13, Issue Supplement_1, pp. S254 - S255
Abstract Background Although anti-TNFα therapy is an effective approach for IBD, a great amount of patients does not respond to induction therapy and a... 
Journal Article